HIV remains a deadly companion to drug-resistant TB in Ukraine

被引：0
作者：
Dahl, V. N. [1 ]
Butova, T. [2 ]
Kuzhko, M. [3 ]
Sapelnik, N. [4 ]
Borysova, O. [4 ]
Pedersen, O. S. [5 ]
Butov, D. [4 ]
机构：
[1] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
[2] Merefa Cent Dist Hosp, Outpatient Dept, Merefa, Ukraine
[3] NAMS Ukraine, Natl Inst Phthisiol & Pulmonol F G Yanovskyi, Dept Chemoresistant TB, Kyiv, Ukraine
[4] Kharkiv Natl Med Univ, Infect Dis & Phthisiol, Kharkiv, Ukraine
[5] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2024年 / 28卷 / 08期
关键词：
tuberculosis; HIV; antiretroviral therapy; mortality; multidrug-resistant TB; outcomes; TREATMENT OUTCOMES; TUBERCULOSIS; MORTALITY; ADULTS; EUROPE;
D O I：
10.5588/ijtld.23.0556
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：400 / 402
页数：3
相关论文
共 50 条
  • [21] Household drug-resistant TB contact tracing in Tajikistan
    Rekart, M. L.
    Aung, A.
    Cullip, T.
    Mulanda, W.
    Mun, L.
    Pirmahmadzoda, B.
    Kliescokova, J.
    Achar, J.
    Alvarez, J. L.
    Sitali, N.
    Sinha, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2023, 27 (10) : 748 - 753
  • [22] Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines
    Santiago, M. R.
    Garfin, A. M. C.
    Balanag, V. M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (10) : 1063 - +
  • [23] Drug-resistant and extensively drug-resistant tuberculosis in southern Africa
    Grobusch, Martin Peter
    CURRENT OPINION IN PULMONARY MEDICINE, 2010, 16 (03) : 180 - 185
  • [24] Treatment Outcomes of Children With HIV Infection and Drug-resistant TB in Three Provinces in South Africa, 2005-2008
    Hall, Eric W.
    Morris, Sapna B.
    Moore, Brittany K.
    Erasmus, Linda
    Odendaal, Ronel
    Menzies, Heather
    van der Walt, Martie
    Smith, Sarah E.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (12) : E322 - E327
  • [25] Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis
    Parrish, Nicole
    Carroll, Karen
    FUTURE MICROBIOLOGY, 2008, 3 (04) : 405 - 413
  • [26] Methods for selecting regimen duration to prevent relapse in drug-susceptible and drug-resistant TB
    Davies, G. R.
    Wallis, R. S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (12) : S13 - S17
  • [27] Loss to follow-up among adults with drug-resistant TB in Papua
    Charles, F.
    Lin, Y. D.
    Greig, J.
    Gurra, S.
    Morikawa, R.
    Graham, S. M.
    Maha, A.
    PUBLIC HEALTH ACTION, 2024, 14 (03):
  • [28] Innovative approach to the design and evaluation of treatment adherence interventions for drug-resistant TB
    Alegria-Flores, K.
    Weiner, B. J.
    Wiesen, C. A.
    Lich, K. L. H.
    Van Rie, A.
    Paul, J. E.
    Tovar, M. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (11) : 1160 - +
  • [29] Data quality assessment of a South African electronic registry for drug-resistant TB, 2015-2016
    Manesen, R.
    Mekler, K. A.
    Molobi, T. R.
    Tyiki, A. A.
    Madlavu, M. J.
    Velen, K.
    Charalambous, S.
    van der Heijden, Y. F.
    PUBLIC HEALTH ACTION, 2021, 11 (01): : 33 - 39
  • [30] Choosing appropriate pharmacotherapy for drug-resistant HIV
    Capetti, Amedeo
    Rizzardini, Giuliano
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 667 - 678
12345